Thursday 9 August | |
TUI Group | Q3 Results |
Randgold Resources | Half Year Results |
Legal & General | Half Year Results |
Cineworld Group | Half Year Results |
Coca-Cola HBC | Half Year Results |
Tritax Big Box REIT | Half Year Results |
Ibstock | Half Year Results |
G4S | Half Year Results |
Card Factory | Trading Statement |
Derwent London | Half Year Results |
Evraz | Half Year Results |
Friday 10 August | |
Volution Group | Half Year Results |
Vitec Group | Trading Statement |
Monday 13 August | |
Clarkson | Half Year Results |
Plus500 | Half Year Results |
Tuesday 14 August | |
Antofagasta | Half Year Results |
esure Group | Half Year Results |
Polypipe | Half Year Results |
Castings | Trading Statement |
John Menzies | Half Year Results |
Mears Group | Half Year Results |
Capital & Regional | Half Year Results |
Apax Alpha Global | Half Year Results |
Wednesday 15 August | |
Marshall Motor | Half Year Results |
Falanx | Full Year Results |
Admiral Group | Half Year Results |
Lookers | Half Year Results |
CLS Holdings | Half Year Results |
Hochschild Mining | Half Year Results |
Balfour Beatty | Half Year Results |
Hikma Pharmaceuticals | Half Year Results |
Riverstone Energy | Half Year Results |
Barclays downgrades Hikma to 'equalweight' on Generics concerns
(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.
Read more